Brief: Jenscare Scientific Says FDA Accepted Early Feasibility Study Of Lux-Valve Plus
07/07/2023 15:27
July 7 (Reuters) - Jenscare Scientific Co Ltd 9877.HK :
* EARLY FEASIBILITY STUDY OF LUX-VALVE PLUS PRE-SUBMISSION
ACCEPTED BY FDA
Further company coverage: 9877.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Jenscare Scientific Co
See all newsBrief: Jenscare Scientific Says Ken-Valve Transcatheter Aortic Valve Replacement System Receives HK Approval
Brief: Jenscare Scientific Posts FY Revenue Of RMB90.6 Million
Brief: Jenscare Scientific Appoints Li Yuanyuan As CFO
Brief: Jenscare Scientific Receives NZ Approval For Ken-Valve And Lux-Valve Plus
Brief: Jenscare Scientific Says Lux-Valve Plus Receives FDA IDE Approval For Pivotal Trial